2-162373482-G-C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_033272.4(KCNH7):​c.3312C>G​(p.Ser1104Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000721 in 1,387,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000072 ( 0 hom. )

Consequence

KCNH7
NM_033272.4 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.30

Publications

0 publications found
Variant links:
Genes affected
KCNH7 (HGNC:18863): (potassium voltage-gated channel subfamily H member 7) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit. There are at least two alternatively spliced transcript variants derived from this gene and encoding distinct isoforms. [provided by RefSeq, Jul 2008]
GCA (HGNC:15990): (grancalcin) This gene encodes a calcium-binding protein that is abundant in neutrophils and macrophages. In the absence of divalent cation, this protein localizes to the cytosolic fraction; with magnesium alone, it partitions with the granule fraction; and in the presence of magnesium and calcium, it associates with both the granule and membrane fractions. Alternative splicing and use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20086104).
BS2
High AC in GnomAdExome4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH7NM_033272.4 linkc.3312C>G p.Ser1104Arg missense_variant Exon 15 of 16 ENST00000332142.10 NP_150375.2 Q9NS40-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH7ENST00000332142.10 linkc.3312C>G p.Ser1104Arg missense_variant Exon 15 of 16 1 NM_033272.4 ENSP00000331727.5 Q9NS40-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000721
AC:
10
AN:
1387620
Hom.:
0
Cov.:
31
AF XY:
0.0000116
AC XY:
8
AN XY:
686986
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30494
American (AMR)
AF:
0.00
AC:
0
AN:
36056
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35874
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74200
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51528
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5482
European-Non Finnish (NFE)
AF:
0.00000279
AC:
3
AN:
1073534
Other (OTH)
AF:
0.000122
AC:
7
AN:
57348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 26, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3312C>G (p.S1104R) alteration is located in exon 15 (coding exon 15) of the KCNH7 gene. This alteration results from a C to G substitution at nucleotide position 3312, causing the serine (S) at amino acid position 1104 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
.;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.049
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.20
T;T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Uncertain
2.0
.;M
PhyloP100
1.3
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.3
.;N
REVEL
Uncertain
0.58
Sift
Benign
0.058
.;T
Sift4G
Benign
0.54
T;T
Polyphen
0.38
.;B
Vest4
0.21
MutPred
0.23
.;Gain of catalytic residue at S1104 (P = 0.0023);
MVP
0.47
MPC
0.10
ClinPred
0.56
D
GERP RS
4.0
Varity_R
0.11
gMVP
0.51
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375047834; hg19: chr2-163229992; API